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Household members and health 
care workers as supervisors of 
tuberculosis treatment
Membros familiares e profissionais 
de saúde na supervisão do 
tratamento da tuberculose
ABSTRACT
OBJECTIVE: To compare tuberculosis cure rates among patients supervised 
by household members or health care workers.
METHODS: Prospective cohort study of 171 patients treated by the  program 
in Vitoria, Southeastern Brazil, from 2004 to 2007. Each patient was followed-
up for six months until the end of the treatment. Of the patients studied, a 
household member supervised 59 patients and healthcare workers supervised 
112 patients. Patients’ sociodemographic and clinic data were analyzed. 
Differences between groups were assessed using chi-square test or Student’s 
t-test. Significance level was set at 5%.
RESULTS: Most patients had smear positive, culture confirmed pulmonary 
tuberculosis. Two patients were HIV-positive. There were more illiterate 
patients in the healthcare-supervised group, in comparison to those supervised 
by their families (p=0.01). All patients supervised by a household member 
were cured compared to 90% of the patients supervised by health care workers 
(p = 0.024).
CONCLUSIONS: Successful tuberculosis treatment was more frequent when 
supervised by household members.
DESCRIPTORS: Tuberculosis, nursing. Homebound Persons. Family 
Nursing. Caregivers. Home Nursing. Medication Therapy Management. 
Treatment Outcome. Cohort Studies.
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Tuberculosis (TB) is a major public health problem 
in developing countries. Since standard short course 
chemotherapy for TB lasts six months and requires 
taking multiple drugs, patients frequently stop taking 
their medications before completion.7 Thus, default is 
the biggest challenge in TB control due to the length 
and complexity of TB treatment.
Multiple strategies have been tried to promote adherence 
and reduce default, the most widely accepted of which is 
directly observed treatment (DOT).4,11 Current technical 
manuals define DOT as direct supervision of medication 
ingestion by a treatment supporter who is acceptable and 
accountable to the patient and to the health system.4
The Directly Observed Therapy Short Course (DOTS), 
strategy advocated by the World Health Organization, 
includes five elements: supervised treatment by DOT, 
case detection by smear microscopy, regular provision 
of high quality drugs, an efficient system for registra-
tion of TB cases and for reporting treatment outcomes, 
and political commitment to TB control.17 Supervised 
therapy where a designated treatment supervisor 
watches the patient swallow each dose of medications 
is a key component of DOTS. When default rates are 
high, many patients are not cured and are at risk for the 
development of acquired drug resistance.3,16
RESUMO
OBJETIVO: Comparar os resultados de cura por tuberculose entre pacientes 
supervisionados pelo membro familiar e pelo profissional de saúde.
MÉTODOS: Estudo de coorte prospectiva de 171 pacientes de Vitória, ES, no 
período de 2004 a 2007. Cada paciente foi acompanhado por seis meses até a 
finalização do tratamento. Dos pacientes estudados, 59 pacientes tratados eram 
supervisionados por um membro familiar e 112 pelos profissionais de saúde. 
Foram avaliados dados sociodemográficos e clínicos dos pacientes. Diferenças 
entre os grupos de estudo foram avaliadas utilizando o teste qui-quadrado ou 
teste t de Student ao nivel de significância de 5%.
RESULTADOS: A maioria dos sujeitos do estudo apresentaram bacioscopia 
positiva e cultura confirmada para tuberculose. Dois pacientes tinham sorologia 
positiva para HIV. Um número maior de pacientes no grupo supervisionado 
por profissionais de saúde não eram alfabetizados, comparado com aqueles 
pacientes do grupo supervisionado por membros familiares (p = 0,01). Todos 
os pacientes supervisionados por um familiar foram curados, frente a 90% dos 
pacientes supervisionados pelos profissionais de saúde (p=0,024).
CONCLUSÕES: O sucesso do tratamento de tuberculose foi maior quando 
supervisionado por um familiar.
DESCRITORES: Tuberculose, enfermagem. Pacientes Domiciliares. 
Enfermagem Familiar. Cuidadores. Assistência Domiciliar. Conduta 
do Tratamento Medicamentoso. Resultado de Tratamento. Estudos de 
Coortes.
INTRODUCTION
Identifying the most practical and cost-effective 
method of supervision that results in the highest cure 
rates is an important issue for the implementation 
of the DOT strategy. A study performed in Ceará, 
Northeastern Brazil, showed that a relationship based 
on respect and friendship between patients, their fami-
lies and health care workers (HCW) was a key factor in 
promoting treatment completion as well as promoting 
active involvement of the patient’s family members 
in anti-TB treatment.6 In another study performed in 
Mexico, treatment completion and cure rates were 
similar in patients supervised by HCW and in those in 
self-administered treatment.15
A recent report by Okanurak et al13 in Bangkok showed 
that treatment completion rates were significantly 
greater when treatment was supervised by a family 
member, compared to supervision by health professio-
nals.13 In a controlled trial in Nepal, treatment supervi-
sion by family members was as effective as treatment 
supervised by health professionals.12 Although these 
results suggest that family members may be satisfactory 
treatment supervisors, there is still no agreement on 
the TB guidelines about the use of family members as 
treatment supervisors by TB control programs.
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a World Health Organization. Global tuberculosis control. (WHO Report 2004) [cited 2008 May 28]. Available from: http://www.who.int/tb/
publications/globalrepor t/2007/en/
In 2001, DOT using household members as treatment 
supervisors was implemented in Vitoria, a large city in 
the Southeast of Brazil, one of the 23 countries with the 
highest global burden of TB. In a previous uncontrolled 
study, we reported high cure rates using domiciliary 
members as treatment supervisors.8
Due to the importance of identifying the most effec-
tive strategy for DOTS supervision, the present article 
aimed to compare default and cure rates among patients 
supervised by household members or HCW.
METHODS
From November 2004 to March 2007, patients with 
newly diagnosed TB, who were treated at a university 
hospital and at a healthcare center in a surrounding poor 
neighborhood of Vitoria, were included in the study. In 
accordance with usual TB program procedures, before 
beginning anti-TB therapy patients chose whether their 
treatment would be supervised by a person living in 
their household (domiciliary supervisor) or a HCW.
All patients diagnosed as a new case were included in the 
study. Patients undergoing secondary TB treatment and 
re-entering after dropouts or relapses were excluded.
Among the 203 new patients with TB treated during the 
study, 32 refused to participate, most frequently due to 
lack of time. The study cohort included 171 patients: 59 
patients chose a domiciliary supervisor and 112 elected 
treatment with a HCW supervisor.
Supervisors who were household members (domicilia-
ry-supervised group) were trained by TB program staff 
to properly administer anti-TB drugs to the patient and 
to mark the patient’s treatment card after each dose was 
administered. Drugs and treatment cards were supplied 
to the household supervisors every other week and were 
reviewed together by the supervisor and a TB program 
worker every other week.
Patients whose supervisors were HCW-supervised 
group attended the outpatient clinic daily for their 
medications. The supervising HCW administered 
their anti-TB drugs and marked their treatment cards. 
Patients who failed to attend clinic for scheduled 
follow-up visits were routinely traced and contacted 
by a HCW from the TB control program. In the 
HCW-supervised group, patients came to the outpatient 
clinic daily between 7 AM and 4 PM to receive their 
DOT. Each HCW supervisor supervised DOT daily for 
three patients on average during the study.
Patients in both groups were followed-up during 
monthly scheduled visits to the TB reference outpa-
tient clinics over the six months of anti-TB treatment. 
Sputum specimens were collected under routine TB 
program conditions before starting treatment and at 
the end of therapy. Sputum smears and cultures on 
Ogawa medium were done at the Mycobacteriology 
Laboratory of the Universidade Federal do Espírito 
Santo, the state TB reference laboratory, according to 
standard procedures.5
Failing to attend clinic for more than one month during 
treatment was defined as default. Treatment cure was 
defined as no clinical signs or symptoms of TB and/or 
having a negative sputum culture after receiving six 
months of anti-TB treatment.
For patient profiles, data on age, sex, education, chest 
radiographic findings, presentation of disease (pulmo-
nary or extrapulmonary TB), HIV status, sputum smear 
and cultures results, supervisor type and treatment 
outcome were obtained from treatment records and 
the TB laboratory.
Data were entered and analyzed using STATA version 9 
(StataCorp, College Station, TX). Differences between 
the groups were assessed by chi-square or Student’s 
t-test, when appropriate. We calculated the relative risk 
(RR) for factors associated with default using bivariate 
analysis. P-values less than 0.05 were considered statis-
tically significant.
The study protocol was approved by the institutional 
review board of the Universidade Federal do Espírito 
Santo.
RESULTS
The baseline characteristics of the participants are 
listed in Table. The age and sex of patients in both 
groups were similar. As is typical in most TB programs 
worldwidea the majority of the patients treated for TB 
in our study (71%) were male. The age range of our 
patients was 18 to 54 years (mean 33 years), reflecting 
the young adult age group most commonly affected by 
TB in high burden countries. Most patients had smear 
positive, culture confirmed pulmonary TB. Although 
the patients in the domiciliary supervisor group had 
more culture positive confirmations than the patients 
supervised by HCW (RR=4.88; 95% CI:1.27;18.72), 
the HCW group had more patients with sputum smear 
grades of 2 to 3+ (67% vs. 52%, p=0.09).
Only two patients in either group were HIV-infected. 
More patients in the HCW supervisor group were 
illiterate compared to those supervised by household 
members (p = 0.01, χ2 test for trend).
In the domiciliary supervisor group, 69.5% (41/59) of 
the supervisors were the patient’s spouse, 24.4% (15/59) 
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were the mother and 5.1% (3/59) were other (father, 
brother, sister, grandmother). Of these supervisors, 56% 
(33/59) worked outside of the home.
All patients whose supervisors were household 
members were cured and 90% of those in the HCW 
supervisor group were cured, a statistically significant 
difference (p=0.024, χ2 test). Two patients in the HCW 
group died during the TB treatment.
DISCUSSION
In a poor urban setting in Brazil, improved treatment 
outcomes can be achieved using household members 
as supervisors of TB treatment as shown in Maciel 
et al’s study.8 We found that cure rates equal or more 
than 90% were achieved during treatment supervised 
by both domiciliary and clinic-based HCW, which 
exceed the Brazilian national TB program target 
cure rate (85%). Our results confirm earlier studies 
from other program settings showing that household 
members are good DOT supervisors and can increase 
adherence and cure rates.1,10,12,18 
Household members appear to be better treatment 
supervisors than HCW in some program settings since 
they may more effectively mobilize a network of family 
support around the patient’s treatment than HCW can. 
The involvement of other household members may be 
decisive for treatment completion and cure.2,9 Besides, 
household members know the patient well and are 
invested in their care. HCW in TB programs are often 
overburdened by many duties, large patient numbers 
and limited transportation for outreach patients and 
treatment supervision.
Our study had some limitations. The non-randomized 
design, where patients chose their own type of super-
visor, precludes definitive statements. Nevertheless, 
a non-randomized design was used because it more 
closely replicates program conditions where newly 
diagnosed TB patients participate in choosing their 
treatment supervisor. Patients with stronger home 
relationships and family resources may have elected to 
have a household member as a treatment supervisor. In 
our study, illiterate patients were more likely to select a 
HCW as their supervisor. Possibly, an illiterate patient 
also has uneducated family members, who can have 
difficulty in recognizing the medication and taking 
notes on the treatment cards, which are required for 
this strategy. The fact that the domiciliary supervisor 
group had approximately five times more patients 
with a confirmed positive culture can be explained 
because the requesting of a culture test is not universal 
for all patients in Brazil. The control program only 
recommends bacilloscopy and culture for diagnosis in 
those cases where a negative bacilloscopy is suspected 
of resulting from drug-resistance, extrapulmonary 
presentation, atypical micobacteria and treatment 
failure.b Our data show a greater number of patients 
with higher sputum smear grades (2 and 3+) in the 
HCW group, compared to the domiciliary supervisor 
a Ministério da Saúde. Programa Nacional de Controle da tuberculose. Brasília: Ministério da Saúde; 2002.
Table. Baseline characteristics of study patients stratified by type of supervision group. Vitória, Southeastern Brazil, 2004-2007.
Variable
Domiciliary supervisor 
(n =59)
Healthcare supervisor 
(n =112)
RR (95% CI) P-value
Sex male – n (%) 39 (66) 80 (71) 0.85 (0.55;1.31) 0.47
Age – mean ± SD 34 (18.2) 33 (19.5) - 0.55
Education– n (%)
None 24 (41) 21(18.7) 0.01
Primary 20 (34) 45 (40.2) -
Middle 14 (24) 16 (14.3)
Secondary or above 1 (2) 6 (5.4)
No information - 24 (21)
HIV-infected – n (%) - 2 (1.8) -a 0.55
Abnormal chest radiograph – n (%) 59 (100) 105 (93.7) - a 0.05
Confirmed TB – n (%) 59 (100) 112 (100) - a -
Disease  presentation
Pulmonary TB – n (%) 59 (100) 98 (87.5) - a 0.003
Extrapulmonary TB – n (%) - 14 (12.5)
Smear positive – n (%) 46 (78) 85 (75.9) 1.08 (0.65;1.78) 0.76
Culture positive – n (%) 57 (90.6) 89 (79.5) 4.88 (1.27;18.72) 0.002
a Exact confidence levels not possible with zero count cells
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group. This fact can be associated with the presen-
tation of moderate and severe tuberculosis,14 which 
could justify less culture requests by the tuberculosis 
control services.
Other unknown factors not included in this study could 
also influence the choice of supervisor and create bias, 
such as religion, distance to health service, type of 
work, drugs use and others. Among the strengths of 
our study are the program setting where it was deve-
loped, including patients representative of persons and 
groups most affected by TB in high burden countries. 
Also, our study presented excellent participation and 
follow-up rates (95%).
The use of household members as supervisors frees up 
resources and HCW time for other important tasks in 
TB control. The feasibility and effectiveness of using 
household members as treatment supervisors may differ 
in different settings and cultures. The good results 
achieved with this strategy in our setting suggest that 
this strategy can be applied in TB programs in Brazil.
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